An Outpatient, Ambulant-Design, Controlled Human Infection Model Using Escalating Doses of Salmonella Typhi Challenge Delivered in Sodium Bicarbonate Solution
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Typhoid fever is a major global health problem, the control of which is hindered by lack of a suitable animal model in which to study Salmonella Typhi infection. Until 1974, a human challenge model advanced understanding of typhoid and was used in vaccine development. We set out to establish a new human challenge model and ascertain the S. Typhi (Quailes strain) inoculum required for an attack rate of 60%-75% in typhoid-naive volunteers when ingested with sodium bicarbonate solution. METHODS: Groups of healthy consenting adults ingested escalating dose levels of S. Typhi and were closely monitored in an outpatient setting for 2 weeks. Antibiotic treatment was initiated if typhoid diagnosis occurred (temperature ≥38°C sustained ≥12 hours or bacteremia) or at day 14 in those remaining untreated. RESULTS: Two dose levels (10(3) or 10(4) colony-forming units) were required to achieve the primary objective, resulting in attack rates of 55% (11/20) or 65% (13/20), respectively. Challenge was well tolerated; 4 of 40 participants fulfilled prespecified criteria for severe infection. Most diagnoses (87.5%) were confirmed by blood culture, and asymptomatic bacteremia and stool shedding of S. Typhi was also observed. Participants who developed typhoid infection demonstrated serological responses to flagellin and lipopolysaccharide antigens by day 14; however, no anti-Vi antibody responses were detected. CONCLUSIONS: Human challenge with a small inoculum of virulent S. Typhi administered in bicarbonate solution can be performed safely using an ambulant-model design to advance understanding of host-pathogen interactions and immunity. This model should expedite development of diagnostics, vaccines, and therapeutics for typhoid control.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3. Kaplan-Meier plots demonstrating time to diagnostic endpoints including all diagnoses (A), those diagnosed using clinical (B) and microbiological (C) criteria, and time to fever (first temperature ≥38°C; [D]) and to first positive blood culture (E), following challenge at 2 dose levels (103 or 104 colony-forming units [CFU]) of Salmonella Typhi (Quailes strain). Shaded gray area, end of 2-week observation period (all remaining participants started on antibiotic therapy); dotted gray line with circle symbols, participants challenged with 103 CFU; dashed black lines with square symbols, participants challenged with 104 CFU.](https://figures.cochat.ai/paper-figures/c29bee3626744f5dbd22d644a7ed99cc/an-outpatient-ambulant-design-controlled-human-infection-model-using-escalating-figure-3.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“An experimental human S. Typhi challenge model was recently reestablished, presenting a unique opportunity to investigate typhoid pathogenesis in a controlled setting in the natural host [5–7].”
From Rapidly Escalating Hepcidin and Associated Serum Iron Starvation Are Features of the Acute Response to Typhoid Infection in Humans (2015) · cites this paper as [7]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
The diagnostic odds ratio: a single indicator of test performance
Glas, A. S., Lijmer, J. G., Prins, M. H., Bonsel, G. J., & Bossuyt, P. M. M. (2003) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(03)00177-x · Cited by 2,261 · cited 1×
“positivity in infection relative to the odds of positivity in the noninfected; 1 indicating that the test does not discriminate between infected and uninfected) [19] and 95% CIs were calculated to assess performance of individual symptoms reported for typhoid diagnosis to be made.”
BackgroundParry, C. M., Hien, T. T., Dougan, G., White, N. J., & Farrar, J. J. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020201 · Cited by 1,112
Self-citationTyphoid fever: pathogenesis and immunologic control
Hornick, R. B., Greisman, S. E., Woodward, T. E., DuPont, H. L., Dawkins, A. T., & Snyder, M. J. (1970) · New England Journal of Medicine · doi:10.1056/nejm197009242831306 · Cited by 565
Acid resistance in enteric bacteria
Gorden, J., & Small, P. L. (1993) · Infection and Immunity · doi:10.1128/iai.61.1.364-367.1993 · Cited by 444 · cited 1×
“For others, such as Shigella dysenteriae or enterotoxigenic Escherichia coli, administration with sodium bicarbonate buffer both reduces the inoculum dose required and results in a more consistent pattern of clinical infection [21–24].”
BackgroundWain, J., Diep, T. S., Ho, V. A., Walsh, A. M., Hoa, N. T. T., Parry, C. M., & White, N. J. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.6.1683-1687.1998 · Cited by 291 · cited 1×
“We found very low numbers of bacteria to be present in the peripheral blood at the time of clinical diagnosis, a finding supported by field data, albeit in an endemic setting [37].”
BackgroundPathogenesis of Shigella dysenteriae 1 (Shiga) Dysentery
Levine, M. M., DuPont, H. L., Formal, S. B., Hornick, R. B., Takeuchi, A., Gangarosa, E. J., Snyder, M. J., & Libonati, J. P. (1973) · Journal of Infectious Diseases · doi:10.1093/infdis/127.3.261 · Cited by 246 · cited 1×
“For others, such as Shigella dysenteriae or enterotoxigenic Escherichia coli, administration with sodium bicarbonate buffer both reduces the inoculum dose required and results in a more consistent pattern of clinical infection [21–24].”
BackgroundEvaluation of a UDP-Glucose-4-Epimeraseless Mutant of Salmonella typhi as a Live Oral Vaccine
Gilman, R. H., Hornick, R. B., Woodward, W. E., DuPont, H. L., Snyder, M. J., Levine, M. M., & Libonati, J. P. (1977) · Journal of Infectious Diseases · doi:10.1093/infdis/136.6.717 · Cited by 217
Typhoid Fever: Pathogenesis and Immunologic Control
Hornick, R. B., Greisman, S. E., Woodward, T. E., DuPont, H. L., Hawkins, A. T., & Snyder, M. J. (1970) · New England Journal of Medicine · doi:10.1056/nejm197010012831406 · Cited by 184 · cited 1×
“In particular, lower levels of pathogen exposure are thought to more closely replicate natural infection and there is less chance of overwhelming any infection- or vaccinederived protective responses seen, an issue noted previously in typhoid challenge/vaccine studies [10, 22, 23, 25].”
BackgroundThe diagnostic significance of relative bradycardia in infectious disease
Cunha, B. A. (2000) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2000.0194f.x · Cited by 136 · cited 1×
“9°C (heart rate <120 bpm) [20].”
Research works printed but not linked: 4
- Standards Unit, 2013, Investigation of faecal specimens for enteric pathogens
- Standards Unit, 2013, Investigation of blood cultures (for organisms other than Mycobacterium species)
- Standards Unit, 2011, Identification of Salmonella species
- Woodard, 1980, Summary of 1886 subjects in volunteer challenges
Cited by
Crump, J. A., Sjölund-Karlsson, M., Gordon, M. A., & Parry, C. M. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00002-15 · Cited by 1,156
“Recent human challenge studies have also demonstrated that a proportion of patients develop a subclinical or asymptomatic bacteremia and that fecal shedding can occur in the period before symptom development, during primary infection (51).”
BackgroundSalmonella enterica Serovar Typhi and the Pathogenesis of Typhoid Fever
Dougan, G., & Baker, S. (2014) · Annual Review of Microbiology · doi:10.1146/annurev-micro-091313-103739 · Cited by 338
Jin, C., Gibani, M. M., Moore, M., Juel, H. B., Jones, E., Meiring, J., Harris, V., Gardner, J., Nebykova, A., Kerridge, S. A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32149-9 · Cited by 313
Self-citationProgress in Typhoid Fever Epidemiology
Crump, J. A. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy846 · Cited by 186
“Human challenge studies demonstrate that fecal shedding and even bacteremia may occur in the absence of clinical signs of typhoid fever [7].”
BackgroundInflammation drives thrombosis after Salmonella infection via CLEC-2 on platelets
Hitchcock, J. R., Cook, C. N., Bobat, S., Ross, E. A., Flores-Langarica, A., Lowe, K. L., Khan, M., Dominguez-Medina, C. C., Lax, S., Carvalho-Gaspar, M., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci79070 · Cited by 175
“In a recent controlled study of typhoid infection in human volunteers, bacteremia occurred in the majority of cases, but subjects had less than 2 bacteria per ml of blood (45).”
BackgroundExperimental infection of human volunteers
Roestenberg, M., Hoogerwerf, M.-A., Ferreira, D. M., Mordmüller, B., & Yazdanbakhsh, M. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30177-4 · Cited by 170
Antibiotic Resistance and Typhoid
Dyson, Z. A., Klemm, E. J., Palmer, S., & Dougan, G. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy1111 · Cited by 156
“Typhi is relatively poorly adapted for growth in the human intestine [5].”
BackgroundDesign, recruitment, and microbiological considerations in human challenge studies
Darton, T. C., Blohmke, C. J., Moorthy, V. S., Altmann, D. M., Hayden, F. G., Clutterbuck, E. A., Levine, M. M., Hill, A. V. S., & Pollard, A. J. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00068-7 · Cited by 130
Self-citationSystems vaccinology: Enabling rational vaccine design with systems biological approaches
Hagan, T., Nakaya, H. I., Subramaniam, S., & Pulendran, B. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.03.072 · Cited by 127
“These systems-based approaches can be used to identify early signatures of efficacy of other vaccines for which human challenge models have been developed, such as typhoid [27, 28] and Shigella [29], enabling rapid”
BackgroundAdvanced model systems and tools for basic and translational human immunology
Wagar, L. E., DiFazio, R. M., & Davis, M. M. (2018) · Genome Medicine · doi:10.1186/s13073-018-0584-8 · Cited by 102
A consensus immune dysregulation framework for sepsis and critical illnesses
Moore, A. R., Zheng, H., Ganesan, A., Hasin-Brumshtein, Y., Maddali, M. V., Levitt, J. E., van der Poll, T., Lu, J., Bouma, H. R., Scicluna, B. P., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03956-5 · Cited by 122
Meiring, J., Khanam, F., Basnyat, B., Charles, R. C., Crump, J. A., Debellut, F., Holt, K. E., Kariuki, S., Mugisha, E. K., Neuzil, K. M., et al. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00480-z · Cited by 121
“Typhi, manufactured under Good Manufacturing Practice, originally derived from the gallbladder of a woman with chronic typhoid infection in Maryland in the 1950s 76,77 .”
InfluentialDarton, T. C., Jones, C., Blohmke, C. J., Waddington, C. S., Zhou, L., Peters, A., Haworth, K., Sie, R., Green, C., Jeppesen, C. A., et al. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004926 · Cited by 94
Self-citationDobinson, H., Gibani, M. M., Jones, C., Thomaides-Brears, H. B., Voysey, M., Darton, T. C., Waddington, C. S., Campbell, D., Milligan, I. D., Zhou, L., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix042 · Cited by 85
“We performed a post hoc comparison of symptom data collected during earlier typhoid challenge studies [11] and noted that paratyphoid challenge resulted in a milder disease profile than that previously observed following typhoid challenge.”
MethodResultInfluentialSelf-citationOverview of the Typhoid Conjugate Vaccine Pipeline: Current Status and Future Plans
Sahastrabuddhe, S., & Saluja, T. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy884 · Cited by 76
“(a wild-type strain originally isolated from a chronic carrier in Baltimore, Maryland), preceded by the ingestion of 120 mL of sodium bicarbonate buffer [29].”
MethodVi-specific serological correlates of protection for typhoid fever
Jin, C., Hill, J. W., Gunn, B. M., Yu, W., Dahora, L. C., Jones, E. A., Johnson, M., Gibani, M. M., Spreng, R. L., Alam, S. M., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20201116 · Cited by 78
“Typhi was calculated to produce an attack rate of 60–75% in naive participants (Waddington et al., 2014).”
BackgroundEnteric Fever Diagnosis: Current Challenges and Future Directions
Neupane, D. P., Dulal, H. P., & Song, J. (2021) · Pathogens · doi:10.3390/pathogens10040410 · Cited by 100
Darton, T. C., Meiring, J., Tonks, S., Khan, A., Khanam, F., Shakya, M., Thindwa, D., Baker, S. G., Basnyat, B., Clemens, J. D., et al. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-016283 · Cited by 73
“Even in ideal conditions, blood culture requires a significant volume of blood to enhance diagnostic yield and is relatively insensitive even in highly controlled human challenge settings where sensitivity reaches 80%.(22) Highly sensitive and specific diagnostic tests are a fundamental requirement for surveillance an…”
BackgroundSalerno-Gonçalves, R., Luo, D., Fresnay, S., Magder, L. S., Darton, T. C., Jones, C., Waddington, C. S., Blohmke, C. J., Angus, B., Levine, M. M., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00398 · Cited by 73
“Typhi Quailes strain, which was first isolated in 1958 from the gallbladder of a known chronic carrier (14, 15, 17).”
BackgroundMethodInfluentialSelf-citationFresnay, S., McArthur, M. A., Magder, L. S., Darton, T. C., Jones, C., Waddington, C. S., Blohmke, C. J., Angus, B., Levine, M. M., Pollard, A. J., et al. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0819-7 · Cited by 68
Self-citationComplex Adaptive Immunity to Enteric Fevers in Humans: Lessons Learned and the Path Forward
Sztein, M. B., Salerno-Gonçalves, R., & McArthur, M. A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00516 · Cited by 77
“Woodward and his collaborators at the University of Maryland led to the successful use of chloramphenicol in the treatment of patients with typhoid fever (61) and also served as the first step toward eventual licensure of the Ty21a typhoid vaccine (63).”
BackgroundInfluentialKhan, M., & Shamim, S. (2022) · Microorganisms · doi:10.3390/microorganisms10102006 · Cited by 84
“Furthermore, there have been studies that suggest a lower count of the bacterium [102,103].”
BackgroundSkurnik, D., Cywes‐Bentley, C., & Pier, G. B. (2016) · Expert Review of Vaccines · doi:10.1586/14760584.2016.1159135 · Cited by 69
“falciparum [66], Hemophilus ducreyi [67], and several GI pathogens [68,69].”
BackgroundBrockett, S., Wolfe, M. K., Hamot, A., Appiah, G. D., Mintz, E. D., & Lantagne, D. (2020) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.19-0479 · Cited by 86
“In addition, variations in population immunity, particularly in endemic settings, may have contributed to variability observed in interventions.(52,53)”
BackgroundVaccinology in the era of high-throughput biology
Nakaya, H. I., & Pulendran, B. (2015) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2014.0146 · Cited by 72
Human challenge trials in vaccine development
Sekhar, A., & Kang, G. (2020) · Seminars in Immunology · doi:10.1016/j.smim.2020.101429 · Cited by 58
McArthur, M. A., Fresnay, S., Magder, L. S., Darton, T. C., Jones, C., Waddington, C. S., Blohmke, C. J., Dougan, G., Angus, B., Levine, M. M., et al. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004914 · Cited by 53
“Typhi (Quailes strain) suspended in sodium bicarbonate at Oxford University in compliance with the National Research Ethic Service (NRES), Oxford Research Ethics Committee A [7].”
BackgroundMethodInfluentialSelf-citationDahora, L. C., Jin, C., Spreng, R. L., Feely, F., Mathura, R., Seaton, K. E., Zhang, L., Hill, J. W., Jones, E. A., Alam, S. M., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02582 · Cited by 58
“Instead, challenge likely induced immuno-dominant responses to alternative antigens such as LPS and flagellin as has been previously described, at least amongst those who developed clinical or microbiological evidence of infection (31).”
BackgroundDetection of Typhoidal and ParatyphoidalSalmonellain Blood by Real-time Polymerase Chain Reaction
Tennant, S. M., Toema, D., Qamar, F. N., Iqbal, N. T., Boyd, M. A., Marshall, J. M., Blackwelder, W. C., Wu, Y., Quadri, F., Khan, A., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ726 · Cited by 49
“monella infection are universally low and many patients have received antibiotics prior to their arrival at the hospital [11, 12].”
BackgroundA Controlled Human Infection Model of Group A Streptococcus Pharyngitis: Which Strain and Why?
Osowicki, J., Azzopardi, K. I., McIntyre, L. C., Rivera-Hernández, T., Ong, C. Y., Baker, C., Gillen, C. M., Walker, M. J., Smeesters, P. R., Davies, M. R., et al. (2019) · mSphere · doi:10.1128/msphere.00647-18 · Cited by 47
“Salmonella enterica serovar Typhi Quailes strain (17).”
Darton, T. C., Zhou, L., Blohmke, C. J., Jones, C., Waddington, C. S., Baker, S. G., & Pollard, A. J. (2017) · Journal of Infection · doi:10.1016/j.jinf.2017.01.006 · Cited by 54
“Stool culture was performed as previously described.(21) Bacterial isolates were identified by phenotypic, biochemical and serological testing according the Kauffmann-White classification, following standard methods.”
BackgroundMethodResultInfluentialSelf-citationGu, X., Plotkin, S. A., Edwards, K. M., Sette, A., Mills, K. H. G., Levy, O., Sant, A. J., Mo, A. X. Y., Alexander, W., Lu, K. T., et al. (2017) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00034-17 · Cited by 47
Darton, T. C., Blohmke, C. J., Giannoulatou, E., Waddington, C. S., Jones, C., Sturges, P., Webster, C., Drakesmith, H., Pollard, A. J., & Armitage, A. E. (2015) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0004029 · Cited by 45
“Full details of the challenge model used in both studies are described in Waddington et al [7].”
BackgroundMethodInfluentialSelf-citationHuman challenge trials in vaccine development, Rockville, MD, USA, September 28–30, 2017
Baay, M. F. D., Richie, T. L., Neels, P., Cavaleri, M., Chilengi, R., Diemert, D. J., Hoffman, S. L., Johnson, R. C., Kirkpatrick, B. D., Knežević, I., et al. (2018) · Biologicals · doi:10.1016/j.biologicals.2018.02.002 · Cited by 48
Blohmke, C. J., Darton, T. C., Jones, C., Suárez, N. M., Waddington, C. S., Angus, B., Zhou, L., Hill, J. W., Clare, S., Kane, L., et al. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20151025 · Cited by 45
“Participants were ambulatory and followed up as outpatients at least daily after challenge when safety, clinical, and laboratory measurements were performed (Waddington et al., 2014).”
InfluentialSelf-citationInvestigation of the role of typhoid toxin in acute typhoid fever in a human challenge model
Gibani, M. M., Jones, E. A., Barton, A., Jin, C., Meek, J., Camara, S., Galal, U., Heinz, E., Rosenberg‐Hasson, Y., Obermoser, G., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0505-4 · Cited by 54
Controlled Human Infection Models To Accelerate Vaccine Development
Choy, R. K. M., Bourgeois, A. L., Ockenhouse, C. F., Walker, R. I., Sheets, R., & Flores, J. (2022) · Clinical Microbiology Reviews · doi:10.1128/cmr.00008-21 · Cited by 59
Galen, J. E., Buskirk, A. D., Tennant, S. M., & Pasetti, M. F. (2016) · EcoSal Plus · doi:10.1128/ecosalplus.esp-0010-2016 · Cited by 54
IntracellularSalmonellametabolism
Bumann, D., & Schothorst, J. (2017) · Cellular Microbiology · doi:10.1111/cmi.12766 · Cited by 48
Identification of Novel Serodiagnostic Signatures of Typhoid Fever Using a Salmonella Proteome Array
Darton, T. C., Baker, S. G., Randall, A. Z., Dongol, S., Karkey, A., Voysey, M., Carter, M. J., Jones, C., Trappl, K., Pablo, J. V., et al. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01794 · Cited by 40
“Ethical approval for the Oxford CHIM studies was provided by the United Kingdom National Research Ethics Service (Oxford Research Ethics Committee A, 10/H0604/53 and 11/SC/0302) (Waddington et al., 2014; Darton et al., 2016).”
BackgroundMethodInfluentialGibani, M. M., Jin, C., Shrestha, S., Moore, M., Norman, L., Voysey, M., Jones, E. A., Blackwell, L., Thomaides-Brears, H. B., Hill, J. W., et al. (2020) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0008783 · Cited by 43
Jin, C., Gibani, M. M., Pennington, S. H., Liu, X., Ardrey, A., Aljayyoussi, G., Moore, M., Angus, B., Parry, C. M., Biagini, G. A., et al. (2019) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0007955 · Cited by 42
“Challenge was performed using frozen cell banks manufactured to Good Manufacturing Practices (GMP) guidelines and stored at -80 ̊C as previously described [24,26,27].”
BackgroundMethodWahid, R., Fresnay, S., Levine, M. M., & Sztein, M. B. (2016) · Clinical Immunology · doi:10.1016/j.clim.2016.09.006 · Cited by 38
Reynolds, C. J., Jones, C., Blohmke, C. J., Darton, T. C., Goudet, A., Sergeant, R., Maillère, B., Pollard, A. J., Altmann, D. M., & Boyton, R. J. (2014) · Immunology · doi:10.1111/imm.12327 · Cited by 35
Fresnay, S., McArthur, M. A., Magder, L. S., Darton, T. C., Jones, C., Waddington, C. S., Blohmke, C. J., Angus, B., Levine, M. M., Pollard, A. J., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00208 · Cited by 36
“org March 2017 | Volume 8 | Article 208 or development of a fever of ≥38°C for ≥12 h, and participants were treated as previously described (8).”
BackgroundMethodResultInfluentialSelf-citationNapolitani, G., Kurupati, P., Teng, K. W. W., Gibani, M. M., Rei, M., Aulicino, A., Preciado‐Llanes, L., Wong, M. T., Becht, É., Howson, L. J., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0133-z · Cited by 35
Thieu, N. T. V., Van, T. T., Tuan, A. T., Klemm, E. J., Minh, C. N. N., Vinh, P. V., Thanh, D. P., Dan, T. H. N., Duc, T. P., Langat, P., et al. (2017) · Journal of Infection · doi:10.1016/j.jinf.2017.05.007 · Cited by 35
Transcriptomics in Human Challenge Models
Barton, A., Hill, J. W., Pollard, A. J., & Blohmke, C. J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01839 · Cited by 34
“org December 2017 | Volume 8 | Article 1839 Indeed at typhoid diagnosis, transcriptional modules associated with B, T, and natural killer cells are underrepresented (9), possibly reflecting the leukopenia observed in typhoid fever (29) or migration of cells to the intestinal mucosa (16, 30, 31).”
BackgroundGibani, M. M., Voysey, M., Jin, C., Jones, C., Thomaides-Brears, H. B., Jones, E. A., Baker, P. E., Morgan, M. R., Simmons, A., Gordon, M. A., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy670 · Cited by 34
“All challenge studies followed comparable protocols, detailed elsewhere (Supplementary Materials) [13, 18, 19, 20, 21, 22].”
BackgroundMethodInfluentialGauld, J., Hu, H., Klein, D. J., & Levine, M. M. (2018) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006759 · Cited by 32
Tissue compartmentalization enables Salmonella persistence during chemotherapy
Li, J., Claudi, B., Fanous, J., Chicherova, N., Cianfanelli, F. R., Campbell, R. A. A., & Bumann, D. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2113951118 · Cited by 33
“Killing activity of antibiotics against invasive Salmonella in human patients is also moderate (78, 79), and Salmonella with slightly reduced susceptibility to fluoroquinolones are associated with longer fever clearance times and increased risk of failure (37, 80), while other Enterobacterales with similarly decreased…”
Heterogeneity of Salmonella-host interactions in infected host tissues
Bumann, D., & Cunrath, O. (2017) · Current Opinion in Microbiology · doi:10.1016/j.mib.2017.09.008 · Cited by 34
Controlled Human Infections As a Tool to Reduce Uncertainty in Clinical Vaccine Development
Roestenberg, M., Kamerling, I. M. C., & de Visser, S. J. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00297 · Cited by 30
“Preferably, these trials target a relevant (clinical) endpoint, addressing a claim in the vaccine target product profile, such as diarrhea in the case of cholera CHI (22) or fever in the case of typhoid CHI (23).”
BackgroundToapanta, F. R., Bernal, P. J., Fresnay, S., Darton, T. C., Jones, C., Waddington, C. S., Blohmke, C. J., Dougan, G., Angus, B., Levine, M. M., et al. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003837 · Cited by 31
Self-citationDiagnostic host gene signature for distinguishing enteric fever from other febrile diseases
Blohmke, C. J., Müller, J., Gibani, M. M., Dobinson, H., Shrestha, S., Perinparajah, S., Jin, C., Hughes, H., Blackwell, L., Dongol, S., et al. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201910431 · Cited by 29
“Blood culture remains the reference standard against which new diagnostic tests are evaluated, and the sensitivity for this test can reach 80% under optimal conditions (Waddington et al, 2014), but low blood volumes and uncontrolled antibiotic use often result in decreased sensitivity in the field.”
BackgroundMethodInfluentialA systematic review and meta-analysis on the incubation period of Campylobacteriosis
Awofisayo-Okuyelu, A., Hall, I., Adak, G. K., Hawker, J. I., Abbott, S., & McCarthy, N. D. (2017) · Epidemiology and Infection · doi:10.1017/s0950268817001303 · Cited by 26
Juel, H. B., Thomaides-Brears, H. B., Darton, T. C., Jones, C., Jones, E. A., Shrestha, S., Sie, R., Eustace, A., Galal, U., Kurupati, P., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01916 · Cited by 26
“Using a controlled human infection model (CHIM) of typhoid fever, the protective efficacy of two live oral attenuated typhoid vaccines (Ty21a and M01ZH09) was recently assessed relative to placebo (14, 15).”
BackgroundMethodResultInfluentialInnis, B. L., Scorza, F. B., Blum, J. S., Jain, V. K., Aguilar, A. M. O., Post, D. J., Roberts, P. C., Wairagkar, N. S., White, J., & Bresee, J. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.06.080 · Cited by 25
“Human challenge models have been used in the development of many other vaccines including cholera and typhoid vaccines [12,13].”
Dyson, Z. A., Thanh, D. P., Bodhidatta, L., Mason, C. J., Srijan, A., Rabaa, M. A., Vinh, P. V., Thanh, T. H., Thwaites, G. E., Baker, S. G., et al. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005274 · Cited by 28
Enteric (typhoid and paratyphoid) fever
Kuehn, R., Rahden, P., Hussain, H. S., Karkey, A., Qamar, F. N., Rupali, P., & Parry, C. M. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01335-2 · Cited by 29
Identification of Protective Antigens for Vaccination against Systemic Salmonellosis
Bumann, D. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00381 · Cited by 24
“Ongoing studies in an experimental human infection and vaccination model (19) will likely provide such crucial information in the near future.”
BackgroundAwofisayo-Okuyelu, A., McCarthy, N. D., Mgbakor, I., & Hall, I. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-3391-3 · Cited by 27
McCullagh, D. J., Dobinson, H., Darton, T. C., Campbell, D., Jones, C., Snape, M. D., Stevens, Z., Plested, E. L., Voysey, M., Kerridge, S. A., et al. (2015) · BMJ Open · doi:10.1136/bmjopen-2014-007481 · Cited by 23
Typhoid vaccine development with a human challenge model
Feasey, N., & Levine, M. M. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32407-8 · Cited by 26
Davies, D. H., Jain, A., Nakajima, R., Liang, L., Jasinskis, A., Supnet, M., Felgner, P. L., Teng, A., Pablo, J. V., Molina, D. M., et al. (2016) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.15-0869 · Cited by 24
Das, S., Chowdhury, R., Ghosh, S., & Das, S. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.07.035 · Cited by 21
Martinón‐Torres, F., Bosch, F. X., Rappuoli, R., Ladhani, S. N., Redondo, E., Vesikari, T., García‐Sastre, A., Calle, I. R., Rial, J. G., Salas, A., et al. (2019) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2019.1609823 · Cited by 21
Oguti, B., Gibani, M. M., Darlow, C. A., Waddington, C. S., Jin, C., Plested, E. L., Campbell, D., Jones, C., Darton, T. C., & Pollard, A. J. (2019) · Wellcome Open Research · doi:10.12688/wellcomeopenres.15469.1 · Cited by 19
Self-citationParatyphoid Fever A: Infection and Prevention
Xie, L., Ming, L., Ding, M., Deng, L., Liu, M., & Cong, Y. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.945235 · Cited by 23
Morton, B., Burr, S. E., Jambo, K., Rylance, J., Henrion, M., Banda, N. P. K., Nsomba, E., Kapumba, B. M., Manda‐Taylor, L., Masesa, C., et al. (2020) · Wellcome Open Research · doi:10.12688/wellcomeopenres.15689.1 · Cited by 18
Ganesan, A., Moore, A. R., Zheng, H., Toh, J., Freedman, M., Magis, A. T., Heath, J. R., & Khatri, P. (2025) · Immunity · doi:10.1016/j.immuni.2025.05.020 · Cited by 20
Meiring, J., Giubilini, A., Savulescu, J., Pitzer, V. E., & Pollard, A. J. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz630 · Cited by 18
“Typhi bacteria and were followed up as previously described [13].”
MethodChronic Salmonella Typhi carriage at sites other than the gallbladder
Hoffman, S. A., Sikorski, M. J., & Levine, M. M. (2023) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0011168 · Cited by 28
Toapanta, F. R., Bernal, P. J., Fresnay, S., Magder, L. S., Darton, T. C., Jones, C., Waddington, C. S., Blohmke, C. J., Angus, B., Levine, M. M., et al. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004766 · Cited by 19
“The clinical results of this study have already been published [11].”
BackgroundMethodResultInfluentialSelf-citationBharmoria, A. (2017) · International Journal of Vaccine Research · doi:10.15226/2473-2176/2/2/00118 · Cited by 21
“bacteremia and that fecal shedding can occur in the period before symptom development, during primary infection [57].”
BackgroundVaccines against Bacterial Enteric Infections
Holmgren, J. R., & Levine, M. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-415847-4.00056-2 · Cited by 18
Khanam, F., Darton, T. C., Meiring, J., Sarker, P. K., Biswas, P. K., Bhuiyan, M. A. I., Rajib, N. H., Tonks, S., Pollard, A. J., Clemens, J. D., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab476 · Cited by 17
“Similarly, after initiation of antibiotic in human challenge model, no shedding was seen [10].”
BackgroundInfluentialInduction of Cell Cycle and NK Cell Responses by Live-Attenuated Oral Vaccines against Typhoid Fever
Blohmke, C. J., Hill, J. W., Darton, T. C., Bürger, M. C., Eustace, A., Jones, C., Schreiber, F., Goodier, M. R., Dougan, G., Nakaya, H. I., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01276 · Cited by 16
“(D) Mean expression of genes within the NK cell-related BTMs in the Ty21a and M01ZH09 group at time point D-21 following vaccination.”
BackgroundMethodInfluentialThe Current Status of Enteric Fever Diagnostics and Implications for Disease Control
Baker, S. G., Blohmke, C. J., Maes, M., Johnston, P. I., & Darton, T. C. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa503 · Cited by 21
“he problem faced by researchers in determining which target(s) to use for new serological tests for enteric fever is demonstrated by human challenge study data from nonendemic settings [6].”
BackgroundHuedo, P., Gori, M., Amato, E., Bianchi, R., Valerio, E., Magnoli, L., & Pontello, M. M. (2016) · Foodborne Pathogens and Disease · doi:10.1089/fpd.2015.2091 · Cited by 16
“Likewise, rates of bacteremia observed for Salmonella Typhi range from 5% to 30%, depending on the dose of ingestion (Waddington et al. , 2014), and gastrointestinal bleeding may develop in up to 10% of hospitalized patients (Crump et al. , 2015).”
Molecular correlates of vaccine-induced protection against typhoid fever
Zhu, H., Chelysheva, I., Cross, D. L., Blackwell, L., Jin, C., Gibani, M. M., Jones, E. A., Hill, J. W., Trück, J., Kelly, D. F., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci169676 · Cited by 16
Enteric fever and its impact on returning travellers
Dave, J., & Sefton, A. Y. (2015) · International Health · doi:10.1093/inthealth/ihv018 · Cited by 15
Roestenberg, M., Mo, A. X. Y., Kremsner, P. G., & Yazdanbakhsh, M. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.10.092 · Cited by 16
Assessing the Feasibility of Typhoid Elimination
Stanaway, J. D., Atuhebwe, P. L., Luby, S. P., & Crump, J. A. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa585 · Cited by 16
“Salmonella Typhi may be shed in the absence of disease [14], and acute, convalescent, and chronic shedding may follow disease.”
BackgroundJones, E. A., Jin, C., Stockdale, L. K., Dold, C., Pollard, A. J., & Hill, J. W. (2021) · Microorganisms · doi:10.3390/microorganisms9071394 · Cited by 18
“Typhi in a CHIM is not enough to cause an increase in Vi antibody levels [19].”
BackgroundDahora, L. C., Verheul, M. K., Williams, K. L., Jin, C., Stockdale, L. K., Cavet, G., Giladi, E., Hill, J. W., Kim, D., Leung, Y., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abj1181 · Cited by 16
Sztein, M. B., & Booth, J. S. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.983403 · Cited by 18
Zhou, L., Jones, C., Gibani, M. M., Dobinson, H., Thomaides-Brears, H. B., Shrestha, S., Blohmke, C. J., Darton, T. C., & Pollard, A. J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150576 · Cited by 14
“Typhi human challenge model with the aim of creating a platform to understand disease pathogenesis, and assess novel vaccine candidates and novel diagnostics [30].”
BackgroundSztein, M. B. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a029546 · Cited by 14
“A wild-type S. Typhi challenge model in humans pioneered at the University of Maryland in the 1950s and 1960s (Hornick et al. 2007) was recently reestablished in Oxford by Dr. Pollard and his team (Waddington et al. 2014).”
BackgroundSalerno-Gonçalves, R., Fresnay, S., Magder, L. S., Darton, T. C., Waddington, C. S., Blohmke, C. J., Angus, B., Levine, M. M., Pollard, A. J., & Sztein, M. B. (2022) · Cellular Immunology · doi:10.1016/j.cellimm.2022.104572 · Cited by 14
Self-citationControl of InvasiveSalmonellaDisease in Africa: Is There a Role for Human Challenge Models?
Gibani, M. M., Jin, C., Darton, T. C., & Pollard, A. J. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ673 · Cited by 18
Levine, M. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35761-6.00061-4 · Cited by 12
Genetic Susceptibility to Enteric Fever in Experimentally Challenged Human Volunteers
Barton, A., Hill, J. W., Bibi, S., Chen, L., Jones, C., Jones, E. A., Camara, S., Shrestha, S., Jin, C., Gibani, M. M., et al. (2022) · Infection and Immunity · doi:10.1128/iai.00389-21 · Cited by 12
Self-citationThe Controlled Human Infection Model for Enterotoxigenic Escherichia coli
Porter, C. K., Talaat, K. R., Isidean, S. D., Kardinaal, A. F. M., Chakraborty, S., Gutiérrez, R. L., Sack, D. A., & Bourgeois, A. L. (2021) · Current topics in microbiology and immunology · doi:10.1007/82_2021_242 · Cited by 8
Darton, T. C., Jones, C., Dongol, S., Voysey, M., Blohmke, C. J., Shrestha, R., Karkey, A., Shakya, M., Arjyal, A., Waddington, C. S., et al. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02031 · Cited by 10
“Blood culture was performed using continuous automated culture (BACTEC FX system, BD), using standard methods (Health Protection Agency, 2013; Waddington et al., 2014).”
BackgroundMethodInfluentialSelf-citationAlugupalli, K. R., Kothari, S., Cravens, M. P., Walker, J. A., Dougharty, D., Dickinson, G. S., Gatto, L. A., Bäumler, A. J., Wangdi, T., Miller, D. R., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-27400-1 · Cited by 13
Jones, C., Darton, T. C., & Pollard, A. J. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00707 · Cited by 11
Rainfall anomalies and typhoid fever in Blantyre, Malawi
Gauld, J., Bilima, S., Diggle, P. J., Feasey, N., & Read, J. M. (2022) · Epidemiology and Infection · doi:10.1017/s0950268822000759 · Cited by 11
“Typhi to a level below that which would be expected to cause typhoid fever, a level which has been quantified through Typhoid live challenge models [17, 20].”
MethodInvasive Salmonella Infections Among Children in Shenzhen, China: A Five-year Retrospective Review
Jiang, M., Wang, H., Zhou, G.-L., Chen, Y.-S., & Deng, J. (2022) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000003588 · Cited by 9
“Typhi can occur in the period before.(25) Similarly, NTS can exist by foodborne transmission and is believed to cause infections in infants with a relative immune deficiency state.”
BackgroundSalmonella Typhi gut invasion drives hypoxic immune subsets associated with disease outcomes
Moshe, N. B. B., Hen‐Avivi, S., Levy-Efrati, L., Veinman, L., Hill, J. W., O’Connor, D., Verheul, M. K., Stockdale, L. K., McLean, F., Pollard, A. J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-62136-8 · Cited by 10
“Typhi challenge studies have been established 25 – 27 .”
Metadata
- Authors
- Waddington, C. S., Darton, T. C., Jones, C., Haworth, K., Peters, A., John, T., Thompson, B. A. V., Kerridge, S. A., Kingsley, R. A., Zhou, L., Holt, K. E., Yu, L.-M., Lockhart, S., Farrar, J. J., Sztein, M. B., Dougan, G., Angus, B., Levine, M. M., & Pollard, A. J.
- Affiliations
- University of Oxford (GB)
- National Institute for Health and Care Research (GB)
- Wellcome Sanger Institute (GB)
- The University of Melbourne (AU)
- Emergent BioSolutions (United Kingdom) (GB)
- University of Maryland, Baltimore (US)
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-02-10
- Volume
- 58
- Issue
- 9
- Pages
- 1230-1240
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC3982839
- OpenAlex
- W2123106908
- Cited by
- 148
- References
- 37
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 3 · 2023: 9 · 2022: 9 · 2021: 8 · 2020: 16 · 2019: 15 · 2018: 11 · 2017: 23 · 2016: 12 · 2015: 14 · 2014: 7
- FWCI
- 26.72
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by
- Locations
- Clinical Infectious Diseases (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- UWA Profiles and Research Repository (UWA) (publishedVersion, other-oa)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Funders
- Wellcome Trust (100891, 092661)
- National Institute for Health and Care Research (ACF-2007-12-003)
- University of Oxford
- National Institutes of Health
- Centers for Disease Control and Prevention
- NIHR Oxford Biomedical Research Centre
- National Institute of Allergy and Infectious Diseases (R01AI036525, U19AI082655)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Salmonella and Campylobacter epidemiology
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Life Sciences › Immunology and Microbiology › Microbiology › Vibrio bacteria research studies
- Keywords
- typhoid fever, Salmonella typhi, human challenge model, controlled human infection model, sodium bicarbonate solution, dose escalation, attack rate, fecal shedding, lipopolysaccharide antigen, Vi antibody
- MeSH terms
- Adolescent, Adult, Ambulatory Care, Antibodies, Bacterial, Female, Humans, Male, Middle Aged, Salmonella typhi, Typhoid Fever, Typhoid-Paratyphoid Vaccines, Bacteremia, Sodium Bicarbonate, Models, Immunological, Host-Pathogen Interactions, Bacterial Shedding
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.